Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,994 public trials 1,520 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)

NCT05529524

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Centre Hospitalier de La Cote Basque; Hematologie Bayonne, France
  • Hopital Claude Huriez; Hematologie Lille, France
  • Institut Paoli Calmettes Marseille, France
  • CHU Saint Eloi; Service d'Hématologie Clinique Montpellier, France
View Trial Details
Completed

Decision Making for Older Adults With Cancer

NCT05374304

Conditions
Cancer, Neoplasms
Locations
  • Zuckerberg San Francisco General Hospital San Francisco, California, United States
  • San Francisco Veterans Medical Center San Francisco, California, United States
  • University of California, San Francisco San Francisco, California, United States
View Trial Details
Completed

A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors

NCT01946789

Conditions
Advanced Solid Tumors, Melanoma, Neoplasm Metastasis, +14 more
Locations
  • University of Minnesota Minneapolis, Minnesota, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
View Trial Details
Completed

A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced Cancers

NCT04350463

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Local Institution - 102 Indianapolis, Indiana, United States
  • Local Institution - 106 New York, United States
  • Local Institution - 105 Canton, Ohio, United States
  • Local Institution - 104 Cleveland, Ohio, United States
View all 37 locations
View Trial Details
Completed

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

NCT03667716

Conditions
Adnexal Diseases, Advanced Cancer, Breast Cancer, +44 more
Locations
  • University of California Los Angeles (UCLA). Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions